InvestorsHub Logo
Followers 5
Posts 528
Boards Moderated 0
Alias Born 07/16/2013

Re: None

Sunday, 04/16/2017 6:32:09 PM

Sunday, April 16, 2017 6:32:09 PM

Post# of 108192
Please feel free to shoot this uneducated theory down; but I believe that Amgen probably bought the rights to the company's key tech (so to speak) when they obtained the rights to the NEO Platform. As we learn more about cancer mutations; I feel that all roads will probably lead to NEO. The base vaccines are probably going to be awesome in their own right; however in instances where they may not attain the necessary efficacy, HOT or NEO will probably be the next logical step. So if you were a BP looking to partner on AXAL, wouldn't you be a little gun shy knowing that this platform will probably be supplemented in the future by NEO and Amgen? And Amgen will probably benefit by AXAL being approved in EU and USA; as I feel that this will probably speed up the overall approval process for NEO. The good news is that we are the manufacturing facility; so I speculate that we will be probably be able to remain independent moving forward. But for me personally, in the future if NEO is approved and I had a cancer that we treat (heaven forbid); I would spend the money and go down the NEO road right off the bat. I am long ADXS and have invested 25% of my 401 K; so I am not trying to bash, just looking at the facts as I see them from an uneducated view point?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News